Better Therapeutics Inc reports results for the quarter ended in March - Earnings Summary

Better Therapeutics

13/05/2022 14:31

* Better Therapeutics Inc  BTTX.OQ  reported a quarterly
adjusted
loss of 41 cents​​ per share for the quarter ended in March. The
mean expectation of three analysts for the quarter was for a
loss of 38 cents per share.
    * Reported revenue was zero​;  analysts expected zero. 
    * Better Therapeutics Inc's reported EPS for the quarter was
a
loss of 41 cents​.
    * The mean earnings estimate of analysts had fallen by
about 42.6%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Better Therapeutics Inc shares had fallen by 7.6% this
quarter and lost 60.6% so far this year.
    * Wall Street's median 12-month price target for Better
Therapeutics Inc is $17.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated May 13 at 01:31 p.m.  ​All
figures in US dollars unless otherwise stated